New study links common arthritis treatments to diabetes risk
NCT ID NCT06011512
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study followed 198 adults aged 50–85 with giant cell arteritis or polymyalgia rheumatica to understand how common treatments (glucocorticoids and interleukin-6 inhibitors) affect diabetes risk. Researchers tracked blood sugar levels and other markers over time. The goal is to identify who is most at risk and improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aalborg University Hospital
Aalborg, North Denmark, 9000, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues in the blood may foretell heart trouble
- New tool could predict who will suffer from steroid side effects
- Shorter steroid course may be just as effective for giant cell arteritis
- New drug could ease painful muscle condition and cut steroid use
- New drug could help patients with painful muscle disease ditch steroids
- New study aims to unravel mysteries of common inflammatory condition in older adults